Iamgold: Q1 Beat and FCF Surge Reinforce BUY Thesis; Valuation at 8x P/E

What happened

IAMGOLD reported Q1 EPS of $0.64, beating consensus of $0.55, and revenue soared 116% to $1.03 billion, driven by high gold prices and the Côté ramp. The company's free cash flow has turned positive and yield exceeds 18%, with net debt/EBITDA at 0.6x and EV/EBITDA around 5.6x. The successful de-risking of Côté to sustained nameplate throughput supports a compelling valuation at 8x normalized EPS, targeting $20/share. However, risks from Burkina Faso security, higher royalties, and ramp variability remain key offsets to the bullish outlook.

Implication

For investors, IAG presents a favorable risk/reward as Côté's ramp generates strong FCF and deleveraging, with a target of $20/share based on 8x normalized EPS. However, the thesis depends on sustained Côté performance and stable Essakane cash flows, while Burkina Faso policy risk and higher royalties at strong gold prices could impair returns. The current valuation embeds a discount for these risks, but any operational slippage or geopolitical disruption could trigger a re-rating lower. Long-term holders should monitor quarterly AISC, Côté recoveries, and Essakane distribution timing as key indicators.

Thesis delta

The thesis remains BUY, but the shift is from a de-risking story to a cash-flow compounding story: Côté has reached steady-state, FCF is surging, and valuation at 8x P/E leaves room for multiple expansion if execution holds. The key delta is that operational risk has diminished, replacing growth capex with FCF generation, but risks (Burkina Faso, royalties, ramp variability) still warrant monitoring.